Dysport competition.
| Autor: | Nash, Karen |
|---|---|
| Předmět: | |
| Zdroj: | Dermatology Times; Oct2009, Vol. 30 Issue 10, p18-20, 2p |
| Abstrakt: | The article reports on the approval of dysport drug, also known as abobotulinumtoxinA, Medicis, by the U.S. Food and Drug Administration. It states that the drug is also used for temporary improvement in the appearance to moderate-to-severe glabellar lines. Boasted as the first serious competitor to Botox, dysport is being used by dermatologists in treating of glabellar lines. |
| Databáze: | Complementary Index |
| Externí odkaz: |
|